IRIS Accounts Production v25.1.4.42 03698954 Board of Directors 1.11.23 31.10.24 31.10.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh036989542023-10-31036989542024-10-31036989542023-11-012024-10-31036989542022-10-31036989542022-11-012023-10-31036989542023-10-3103698954ns15:EnglandWales2023-11-012024-10-3103698954ns14:PoundSterling2023-11-012024-10-3103698954ns10:Director12023-11-012024-10-3103698954ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3103698954ns10:SmallEntities2023-11-012024-10-3103698954ns10:AuditExemptWithAccountantsReport2023-11-012024-10-3103698954ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3103698954ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3103698954ns10:FullAccounts2023-11-012024-10-3103698954ns10:Director22023-11-012024-10-3103698954ns10:CompanySecretary12023-11-012024-10-3103698954ns10:RegisteredOffice2023-11-012024-10-3103698954ns5:CurrentFinancialInstruments2024-10-3103698954ns5:CurrentFinancialInstruments2023-10-3103698954ns5:ShareCapital2024-10-3103698954ns5:ShareCapital2023-10-3103698954ns5:RetainedEarningsAccumulatedLosses2024-10-3103698954ns5:RetainedEarningsAccumulatedLosses2023-10-3103698954ns5:LeaseholdImprovements2023-11-012024-10-3103698954ns5:PlantMachinery2023-11-012024-10-3103698954ns5:FurnitureFittings2023-11-012024-10-3103698954ns5:MotorVehicles2023-11-012024-10-3103698954ns5:ComputerEquipment2023-11-012024-10-3103698954ns5:LeaseholdImprovements2023-10-3103698954ns5:PlantMachinery2023-10-3103698954ns5:FurnitureFittings2023-10-3103698954ns5:LeaseholdImprovements2024-10-3103698954ns5:PlantMachinery2024-10-3103698954ns5:FurnitureFittings2024-10-3103698954ns5:LeaseholdImprovements2023-10-3103698954ns5:PlantMachinery2023-10-3103698954ns5:FurnitureFittings2023-10-3103698954ns5:MotorVehicles2023-10-3103698954ns5:ComputerEquipment2023-10-3103698954ns5:MotorVehicles2024-10-3103698954ns5:ComputerEquipment2024-10-3103698954ns5:MotorVehicles2023-10-3103698954ns5:ComputerEquipment2023-10-3103698954ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3103698954ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-3103698954ns5:DeferredTaxation2023-10-3103698954ns5:DeferredTaxation2024-10-31036989541ns10:Director12023-10-31036989541ns10:Director12022-10-31036989541ns10:Director12023-11-012024-10-31036989541ns10:Director12022-11-012023-10-31036989541ns10:Director12024-10-31036989541ns10:Director12023-10-31
REGISTERED NUMBER: 03698954 (England and Wales)










A & M PHARMACIES LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2024






A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Certified Accountants' Report 7

A & M PHARMACIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 OCTOBER 2024







DIRECTORS: Mr A L Hindocha
Mrs M A Hindocha





SECRETARY: Mrs M A Hindocha





REGISTERED OFFICE: 126 Sutherland Avenue
Coventry
West Midlands
CV5 7NJ





REGISTERED NUMBER: 03698954 (England and Wales)





ACCOUNTANTS: Shah & Co (Accountants) Ltd
Chartered Certified Accountants
Cash's Business Centre
1st Floor
228 Widdrington Road
Coventry
West Midlands
CV1 4PB

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

BALANCE SHEET
31 OCTOBER 2024

31.10.24 31.10.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 105,072 118,045

CURRENT ASSETS
Stocks 209,233 167,847
Debtors 5 289,487 444,840
Cash at bank and in hand 421,073 311,339
919,793 924,026
CREDITORS
Amounts falling due within one year 6 (431,923 ) (374,416 )
NET CURRENT ASSETS 487,870 549,610
TOTAL ASSETS LESS CURRENT
LIABILITIES

592,942

667,655

PROVISIONS FOR LIABILITIES 7 (10,856 ) (13,274 )
NET ASSETS 582,086 654,381

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 581,986 654,281
SHAREHOLDERS' FUNDS 582,086 654,381

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

BALANCE SHEET - continued
31 OCTOBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 March 2025 and were signed on its behalf by:





Mr A L Hindocha - Director


A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024

1. STATUTORY INFORMATION

A & M Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 15% on reducing balance
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 38 (2023 - 33 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings
£    £    £   
COST
At 1 November 2023 318,688 58,355 460,662
Additions - - -
At 31 October 2024 318,688 58,355 460,662
DEPRECIATION
At 1 November 2023 278,448 45,302 421,807
Charge for year 6,036 1,958 5,828
At 31 October 2024 284,484 47,260 427,635
NET BOOK VALUE
At 31 October 2024 34,204 11,095 33,027
At 31 October 2023 40,240 13,053 38,855

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 November 2023 15,130 80,745 933,580
Additions - 6,302 6,302
At 31 October 2024 15,130 87,047 939,882
DEPRECIATION
At 1 November 2023 8,892 61,086 815,535
Charge for year 1,559 3,894 19,275
At 31 October 2024 10,451 64,980 834,810
NET BOOK VALUE
At 31 October 2024 4,679 22,067 105,072
At 31 October 2023 6,238 19,659 118,045

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Trade debtors (388 ) 20,075
Other debtors 289,875 424,765
289,487 444,840

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.24 31.10.23
£    £   
Trade creditors 379,343 277,501
Taxation and social security 20,467 36,507
Other creditors 32,113 60,408
431,923 374,416

7. PROVISIONS FOR LIABILITIES
31.10.24 31.10.23
£    £   
Deferred tax 10,856 13,274

Deferred
tax
£   
Balance at 1 November 2023 13,274
Decrease in provision (2,418 )
Balance at 31 October 2024 10,856

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2024 and 31 October 2023:

31.10.24 31.10.23
£    £   
Mr A L Hindocha
Balance outstanding at start of year 130,000 -
Amounts advanced - 130,000
Amounts repaid (130,000 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 130,000

During the year rent was paid to the directors Mr. & Mrs. A Hindocha on normal commercial terms. The rent was for the premises at Mount Nod in Coventry, the amounts paid were £15,000 (2023- £15,000).

Included within the creditors, the amount owed to the directors is £ 9,474 (2023 £ 3,365 ).These loans are interest free and with no fixed date of repayment.

9. ULTIMATE CONTROLLING PARTY

The controlling party is Mr & Mrs Hindocha.

CHARTERED CERTIFIED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
A & M PHARMACIES LIMITED

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of A & M Pharmacies Limited for the year ended 31 October 2024 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the Board of Directors of A & M Pharmacies Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of A & M Pharmacies Limited and state those matters that we have agreed to state to the Board of Directors of A & M Pharmacies Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at
https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that A & M Pharmacies Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of A & M Pharmacies Limited. You consider that A & M Pharmacies Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of A & M Pharmacies Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Shah & Co (Accountants) Ltd
Chartered Certified Accountants
Cash's Business Centre
1st Floor
228 Widdrington Road
Coventry
West Midlands
CV1 4PB


19 March 2025